This study is a follow-on, open-label extension of a double-blind study. For subjects who achieved gabapentin monotherapy during the double-blind study, the purpose of this study is to evaluate long term safety of gabapentin. For subjects who did not achieve gabapentin monotherapy during the double-blind protocol, the objectives are to evaluate long term safety of gabapentin and to determine the percentage of patients who achieve gabapentin monotherapy in this study.
Showing the most recent 10 out of 459 publications